ERECTILE DYSFUNCTION IN PATIENTS WITH METABOLIC SYNDROME


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

There is more and more evidence supporting the difference in the association between metabolic syndrome and erectile dysfunction. Endothelial dysfunction that can cause different penile vascular disorders may be a mechanism that combines these diseases.

Full Text

Restricted Access

About the authors

S. Gamidov

Acad. V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology; N.I. Pirogov Russian National Research Medical University

Email: docend2@rambler.ru
Professor MD Moscow

P. Ovchinnikov

Acad. V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: docend2@rambler.ru
Candidate of Medical Sciences Moscow

A. Popova

Acad. V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: docend2@rambler.ru
Candidate of Medical Sciences Moscow

K. Kramareva

N.I. Pirogov Russian National Research Medical University

Email: docend2@rambler.ru
Moscow

P. Nikitin

N.I. Pirogov Russian National Research Medical University

Email: docend2@rambler.ru
Moscow

References

  1. Feldman H., Goldstein I., Hatzichristou D. et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study // J. Urol. - 1994; 151: 151-4.
  2. Ayta I., McKinlay J., Krane R. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. // BJU Int. - 1999; 84: 50-6.
  3. Morales A., Johnston B., Heaton J. еt al. Testosterone supplementation in hypogonadal impotence. Assessment of biochemical measurements and therapeutic outcomes // J. Urol. - 1997; 157: 849-54.
  4. Мамедов М.Н., Перова Н.В., Метельская В.А. и др. Взаимосвязь абдоминального типа ожирения и синдрома инсулинорезистентности у больных артериальной гипертонией // Кардиология. - 1999; 9: 18-22.
  5. Задионченко В.С., Адашева Т.В., Демичева О.Ю. и др. Артериальная гипертония при метаболическом синдроме: патогенез, основы терапии // Consilium Medicum. - 2004; 6 (9).
  6. Esposito K., Giugliano F., Martedi E. et al. High proportions of erectile dysfunction in men with the metabolic syndrome // Diabetes Care. - 2005; 28 (5): 1201-3.
  7. Rajfer J. Endothelial dysfunction as a cause of erectile dysfunction--misdiagnosis or misnomer? // Urology. - 2004; 64: 193-4.
  8. Марков Х.М. Молекулярные механизмы дисфункции сосудистого эндотелия // Кардиология. - 2005; 12: 62-7.
  9. Dzau V., Gibbons G. Endothelium and growth factors in vascular remodelling of hypertension // Hypertension. - 1991; 18 (III): 115-21.
  10. Мазо Е.Б., Зубарев А.Р., Жуков О.Б. Ультразвуковая диагностика васкулогенной эректильной дисфункции / М.: Медицина. - 2003.
  11. Fogari R., Zoppi A., Poletti L. et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study // Am. J. Hypertens. - 2001; 14 (1): 27-31.
  12. Jackson G. Simvastatin and impotence [letter] // BMJ. - 1997; 315: 31.
  13. Carani C., Zini D., Baldini A. et al. Effects of androgen treatment in impotent men with normal and low levels of free testosterone // Arch. Sex. Behav. - 1990; 19: 223-34.
  14. Nehra A., Kulaksizoglu H. Combination treatment for erectile dysfunction: where we are and what’s in the future // Current. Urol. Rep. - 2002; 3: 467-70.
  15. Мычка В.Б. и др. Медикаментозное лечение ожирения больных с метаболическим синдромом // Кардиоваск. тер. и профилакт. - 2005; 4: 79-84.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Russkiy Vrach Publishing House